Importance  

Diabetic kidney disease (DKD) and its comorbidities can be prevented by treating multiple targets. Technology-assisted team-based care with regular feedback and patient empowerment can improve the attainment of multiple targets and clinical outcomes in patients with type 2 diabetes, but the effects of this intervention on patients with DKD are unclear.

Objective  

To evaluate the effect of the Joint Asia Diabetes Evaluation (JADE) web portal, nurse reminders, and team-based care on multiple risk factors in patients with DKD.

Design, Setting, and Participants  

This 12-month multinational, open-label randomized clinical trial was conducted between June 27, 2014, and February 19, 2019, at 13 hospital-based diabetes centers in 8 countries or regions in Asia. All patients who participated had DKD. The intention-to-treat data analysis was performed from April 7 to June 30, 2020.

Interventions  

Patients were randomized in a 1:1:1 ratio at each site to usual care, empowered care, or team-based empowered care. All patients underwent a JADE web portal–guided structured assessment at baseline and month 12. Patients in the usual care and empowered care groups received a medical follow-up. Patients in the empowered care group also received a personalized JADE report and nurse telephone calls every 3 months. Patients in the team-based empowered care group received additional face-to-face reviews every 3 months from a physician-nurse team.

Main Outcomes and Measures  

The primary outcome was the proportion of patients who attained multiple treatment targets (defined as ≥3 of 5 targets: HbA_1c level <7.0% [53 mmol/mol], blood pressure <130/80 mm Hg, low-density lipoprotein cholesterol level <1.8 mmol/L, triglyceride level <1.7 mmol/L, and/or persistent use of renin-angiotensin-aldosterone system inhibitors).

Results  

A total of 2393 patients (mean [SD] age, 67.7 [9.8] years; 1267 men [52.9%]) were randomized to the usual care group (n = 795), empowered care group (n = 802), and team-based empowered care group (n = 796). At baseline, 34.7% patients (n = 830) were on 3 treatment targets. On intention-to-treat analysis, the team-based empowered care group had the highest proportion of patients who had further increase in attainment of multiple treatment targets (within-group differences: usual care group, 3.9% [95% CI, 0.0%-7.8%]; empowered care group, 1.3% [95% CI, −2.8% to 5.4%]; team-based empowered care group, 9.1% [95% CI, 4.7%-13.5%]). The team-based empowered care group was more likely to attain multiple treatment targets than the usual care group (risk ratio [RR], 1.17; 95% CI, 1.00-1.37) and the empowered care group (RR, 1.25; 95% CI, 1.06-1.48) after adjustment for site. Compared with the group that did not attain multiple treatment targets, the group that attained multiple treatment targets reported a lower incidence of cardiovascular, kidney, and cancer events (8.4% [n = 51] vs 14.5% [n = 134]; P = .004). Analysis of the per-protocol population yielded similar results.

Conclusions and Relevance  

This trial found that technology-assisted team-based care for 12 months improved the attainment of multiple treatment targets as well as empowerment in patients with DKD.

1. de Boer, I. H., Caramori, M. L., Chan, J. C. N., Aristimuno, G. G., Carioni, M., Gilbert, R. E., ... & Khunti, K. (2020). Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: Evidence-based advances in monitoring and treatment. Kidney International, 98(4), 839–848. https://doi.org/10.1016/j.kint.2020.06.024
2. González-Pérez, A., Saez, M., Vizcaya, D., Lind, M., & Garcia Rodriguez, L. (2021). Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: A population-based cohort study in the UK. BMJ Open Diabetes Research & Care, 9(1), Article e002146. https://doi.org/10.1136/bmjdrc-2021-002146
3. Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015). Blood pressure lowering in type 2 diabetes: A systematic review and meta-analysis. JAMA, 313(6), 603–615. https://doi.org/10.1001/jama.2014.18574
4. Patel, A., MacMahon, S., Chalmers, J., Neal, B., Billot, L., Woodward, M., ... & ADVANCE Collaborative Group. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560–2572. https://doi.org/10.1056/NEJMoa0802987
5. Shepherd, J., Kastelein, J. J., Bittner, V., Deedwania, P., Breazna, A., Dobson, S., ... & Treating to New Targets Investigators. (2007). Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study. Clinical Journal of the American Society of Nephrology, 2(6), 1131–1139. https://doi.org/10.2215/CJN.04371206
6. Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H. H., ... & RENAAL Study Investigators. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine, 345(12), 861–869. https://doi.org/10.1056/NEJMoa011161
7. Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., ... & CREDENCE Trial Investigators. (2019). Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. New England Journal of Medicine, 380(24), 2295–2306. https://doi.org/10.1056/NEJMoa1811744
8. Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., ... & DAPA-CKD Trial Committees and Investigators. (2020). Dapagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 383(15), 1436–1446. https://doi.org/10.1056/NEJMoa2024816
9. Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, P., ... & FIDELIO-DKD Investigators. (2020). Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. New England Journal of Medicine, 383(23), 2219–2229. https://doi.org/10.1056/NEJMoa2025845
10. Aschner, P., Gagliardino, J. J., Ilkova, H., Lavalle, F., Ramachandran, A., Mbanya, J. C., ... & Chan, J. C. (2020). Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS). Diabetologia, 63(4), 711–721. https://doi.org/10.1007/s00125-019-05078-3
11. Chan, J. C. N., Lim, L. L., Luk, A. O. Y., Ozaki, R., Kong, A. P. S., Ma, R. C. W., & So, W.Y. (2019). From Hong Kong Diabetes Register to JADE Program to RAMP-DM for data-driven actions. Diabetes Care, 42(11), 2022–2031. https://doi.org/10.2337/dci19-0003
12. Yeung, R. O., Zhang,Y., Luk, A., Yang, W., Chow, C. C., Li, X., ... & JADE Program. (2014). Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): A cross-sectional study of a prospective cohort. The Lancet Diabetes & Endocrinology, 2(12), 935–943. https://doi.org/10.1016/S2213-8587(14)70137-8
13. Luk, A. O., Li, X., Zhang,Y., Lau, E. S., Yang, W.Y., Kim, B. S., ... & JADE Study Group. (2016). Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) registry. Diabetic Medicine, 33(9), 1230–1239. https://doi.org/10.1111/dme.13014
14. Lo, C., Teede, H., Fulcher, G., Gallagher, M., Kerr, P. G., Russell, G., ... & Zoungas, S. (2017). Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: A cross-sectional study. BMC Nephrology, 18(1), Article 80. https://doi.org/10.1186/s12882-017-0493-x
15. Lim, L. L., Lau, E. S. H., Kong, A. P. S., Davies, M. J., Levitt, N. S., Eliasson, B., ... & Chan, J. C. N. (2018). Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: A systematic review and meta-analysis. Diabetes Care, 41(6), 1312–1320. https://doi.org/10.2337/dc17-2010
16. Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Levin, A., Coresh, J., ... & Conference Participants. (2021). The case for early identification and intervention of chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 99(1), 34–47. https://doi.org/10.1016/j.kint.2020.10.012
17. World Medical Association. (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191–2194. https://doi.org/10.1001/jama.2013.281053
18. Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang,Y. L., Castro, A. F., Feldman, H. I., ... & CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
19. Ko, G. T., So, W.Y., Tong, P. C., Chow, C. C., Yeung, C.Y., Chan, W. B., ... & Chan, J. C. (2010). From design to implementation–the Joint Asia Diabetes Evaluation (JADE) program: A descriptive report of an electronic web-based diabetes management program. BMC Medical Informatics and Decision Making, 10, Article 26. https://doi.org/10.1186/1472-6947-10-26
20. Chan, J., So, W., Ko, G., Tong, P., Yang, W., Kim, S., ... & JADE Study Group. (2009). The Joint Asia Diabetes Evaluation (JADE) program: A web-based program to translate evidence to clinical practice in type 2 diabetes. Diabetic Medicine, 26(7), 693–699. https://doi.org/10.1111/j.1464-5491.2009.02751.x
21. Chan, J. C. N., Lim, L. L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., ... & Lancet Commission on Diabetes. (2021). The Lancet Commission on diabetes: Using data to transform diabetes care and patient lives. The Lancet, 396(10267), 2019–2082. https://doi.org/10.1016/S0140-6736(20)32374-6
22. Ray, K. K., Seshasai, S. R., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., ... & Sattar, N. (2009). Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. The Lancet, 373(9677), 1765–1772. https://doi.org/10.1016/S0140-6736(09)60697-8
23. Kearney, P. M., Blackwell, L., Collins, R., Keech, A., Simes, J., Peto, R., ... & Cholesterol Treatment Trialists’ (CTT) Collaborators. (2008). Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis. The Lancet, 371(9607), 117–125. https://doi.org/10.1016/S0140-6736(08)60104-X
24. Chan, J. C., So, W.Y., Yeung, C.Y., Ko, G. T., Lau, I. T., Tsang, M. W., ... & SURE Study Group. (2009). Effects of structured versus usual care on renal endpoint in type 2 diabetes: The SURE study: A randomized multicenter translational study. Diabetes Care, 32(6), 977–982. https://doi.org/10.2337/dc08-1908
25. van Buuren, S., & Groothuis-Oudshoorn, K. (2011). mice: Multivariate imputation by chained equations in R. Journal of Statistical Software, 45(3), 1–67. https://doi.org/10.18637/jss.v045.i03
26. Barnard, J., & Rubin, D. B. (1999). Miscellanea: Small-sample degrees of freedom with multiple imputation. Biometrika, 86(4), 948–955. https://doi.org/10.1093/biomet/86.4.948
27. R Core Team. (2020). R: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/
28. Oellgaard, J., Gæde, P., Rossing, P., Persson, F., Parving, H. H., & Pedersen, O. (2017). Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. Kidney International, 91(4), 982–988. https://doi.org/10.1016/j.kint.2016.11.023
29. Ueki, K., Sasako, T., Okazaki,Y., Kato, M., Okahata, S., Katsuyama, H., ... & J-DOIT3 Study Group. (2020). Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney International, 99(1), 256–266. https://doi.org/10.1016/j.kint.2020.08.012
30. Tonelli, M., Nkunu,V., Varghese, C., Ahsan, S. S., Alrukhaimi, M., Ashuntantang, G., ... & Integrated Kidney Care Programs Working Group. (2020). Framework for establishing integrated kidney care programs in low- and middle-income countries. Kidney International Supplements, 10(1), e19–e23. https://doi.org/10.1016/j.kisu.2019.11.002
31. Lim, L. L., Lau, E. S. H., Fu, A. W. C., Luk, A. O.Y., Chow, C. C., Tsang, M. W., ... & Asia-Pacific JADE Study Group. (2021). Effects of a technology-assisted integrated diabetes care program on cardiometabolic risk factors among patients with type 2 diabetes in the Asia-Pacific region: The JADE program randomized clinical trial. JAMA Network Open, 4(4), Article e217557. https://doi.org/10.1001/jamanetworkopen.2021.7557
32. American Diabetes Association. (2021). 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes–2021. Diabetes Care, 44(Suppl 1), S40–S52. https://doi.org/10.2337/dc21-S004
33. Chatterjee, S., Davies, M. J., Heller, S., Speight, J., Snoek, F. J., & Khunti, K. (2018). Diabetes structured self-management education programmes: A narrative review and current innovations. The Lancet Diabetes & Endocrinology, 6(2), 130–142. https://doi.org/10.1016/S2213-8587(17)30239-5
34. Tutino, G. E., Yang, W.Y., Li, X., Luk, A. O., So, W.Y., Ko, G. T., ... & China JADE Study Group. (2017). A multicentre demonstration project to evaluate the effectiveness and acceptability of the web-based Joint Asia Diabetes Evaluation (JADE) programme with or without nurse support in Chinese patients with type 2 diabetes. Diabetic Medicine, 34(3), 440–450. https://doi.org/10.1111/dme.13164
35. Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The Lancet, 389(10085), 2239–2251. https://doi.org/10.1016/S0140-6736(17)30058-2
36. Chan, J. C., Ozaki, R., Luk, A., So, W.Y., Chow, C. C., & JADE Collaborative Study Group. (2014). Delivery of integrated diabetes care using logistics and information technology–the Joint Asia Diabetes Evaluation (JADE) program. Diabetes Research and Clinical Practice, 106(Suppl 2), S295–S304. https://doi.org/10.1016/S0168-8227(14)70733-8
37. Lim, L. L., Lau, E. S. H., Ozaki, R., Hookham, C., Chan, M. H. M., Ma, R. C. W., ... & Chan, J. C. N. (2020). Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis. PLoS Medicine, 17(10), Article e1003367. https://doi.org/10.1371/journal.pmed.1003367